drugset / Trial / NCT02084953
Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects
RandomizedCrossoverQuadruple-blind
Summary
The purpose of this study is to determine whether BMS-791325 has an effect on the electrocardiogram (ECG) interval QT corrected for Fridericia's method (QTcF).
Timeline
- Start
- 2014-04
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclabuvir | Small molecule | 900 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |